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  THE NEED FOR PERIPHERAL TOLERANCE TO ANTIGEN IN 
THE INTESTINE 
 During lymphocyte differentiation, a virtually unlimited reper-
toire of B- and T-cell receptors is generated to recognize all kinds 
of different antigens. As a result, a large number of developing 
lymphocytes will have receptors that can react to self-antigens, as 
well as innocuous foreign antigens such as food and commensal 
bacteria. Deleterious immune responses against self-antigens 
are normally prevented by the process of negative selection 
or central tolerance, in which developing T and B cells in the 
thymus and bone marrow are eliminated from the repertoire. 
Additionally, some T cells recognizing self-antigen with high 
affinity will express the transcription factor Foxp3 (forkhead 
box P3) and become natural regulatory T cells (nTregs). Both 
central tolerance of T cells and nTreg differentiation require the 
interaction of the T-cell receptor with its cognate antigen in the 
thymus. Consequently, both of these mechanisms are unsuited 
for preventing responses against antigens such as those coming 
from the intestine and that are not present or expressed at the 
sites of lymphocyte differentiation. Thus, additional layers of 
peripheral tolerance are needed to ensure tolerance to antigens 
such as foods and commensal organisms.     
  MUCOSALLY INDUCED TOLERANCE TO ANTIGEN IN 
THE INTESTINE 
 The intestine is exposed continuously to vast amounts of foreign 
antigenic material. As well as ingesting     >    100   g of foreign protein 
per day in our diet, the intestine is colonized by a dense commu-
nity of commensal microbes, referred to as the microbiota. The 
density of these microbes increases along the gastrointestinal 
tract, reaching up to 10  12  bacteria per gram of gut content in the 
colon. At the same time, the mucosal barriers are thin and very 
vulnerable to pathogenic infection, meaning that the intestinal 
immune system has to discriminate between generating protec-
tive immunity against harmful antigens and tolerance against 
harmless materials. Active immune responses directed against 
the microbiota can result in inflammatory bowel diseases such as 
Crohn  ’  s disease and ulcerative colitis. The incidence of Crohn  ’  s 
disease and ulcerative colitis is increasing throughout the world 
and in some countries can affect up to 0.6 %  of the population.  1  
Failure to induce tolerance to food protein is thought to result in 
food allergy and celiac disease, which is the most prevalent food-
induced pathology.  2   The ability of orally administered antigen 
to suppress subsequent immune responses, both in the gut and 
in the systemic immune system, was first described 100 years 
ago and has been studied widely since.  3,4   This phenomenon is 
referred to as  “ oral tolerance ”  and its effects on systemic immu-
nity have led to attempts to exploit it therapeutically to prevent 
or treat autoimmune diseases (reviewed in ref. 5    ). However, 
there is an important difference between tolerance to gut bac-
teria and tolerance to food proteins: whereas tolerance to food 
protein induced via the small intestine affects local and systemic 
immune responses, tolerance to gut bacteria in the colon does 
not attenuate systemic responses. Such differences are frequently 
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overlooked in the field and the term oral tolerance is often used 
interchangeably to describe tolerance to food protein and bacte-
ria. In our opinion, this arbitrary terminology is misleading and 
has hampered a better understanding of the underlying proc-
esses. Here we will use   “  oral tolerance  ”   to describe tolerance to 
orally administered soluble antigens and will discuss its role in 
the broader context of  “ mucosally induced tolerance ”  that can be 
induced by other antigens in different parts of the intestine.     
  ORAL TOLERANCE: SCOPE AND EFFECTS 
  Oral tolerance has been demonstrated extensively in rodents 
using many different model antigens including purified pro-
teins, cellular antigens, and small haptens, and it has also been 
shown in humans.  6 – 8  The effects of oral tolerance are measured 
typically as reductions in systemic delayed-type hypersensitivity, 
T-cell proliferation, and cytokine production. Serum antibody 
responses can also be suppressed, particularly immunoglobulin 
E (IgE) and T helper type 1-dependent IgG2a production, as can 
mucosal T-cell and immunoglobulin A responses. Moreover, 
oral tolerance has been shown to suppress immunopathology 
in experimental models of autoimmune encephalitis,  9   colla-
gen-induced arthritis,  10  type 1 diabetes,  11  and others (see ref. 5   
for review). Thus, oral tolerance attenuates a broad range of 
immune responses and appears to play a central role in immune 
homeostasis. 
  As the basic aspects of oral tolerance have been reviewed 
exhaustively over the years,  4,5,12   here we will concentrate on 
aspects that have attracted particular interest recently. First, we 
will discuss the routes by which antigen is taken up in the intes-
tine and where tolerance is induced. Second, we will discuss 
the mechanisms that underlie local and systemic tolerance to 
orally administered antigens, before presenting a framework 
that might underpin future mechanistic studies.     
  MECHANISMS OF ANTIGEN UPTAKE IN THE INTESTINE 
 The intestinal immune system can be divided into inductive and 
effector sites. Inductive sites include the gut-associated lymphoid 
tissues (GALT) such as Peyer ’ s patches (PP) and isolated lymphoid 
follicles and the gut-draining mesenteric lymph nodes (mLNs); 
the lamina propria (LP) and epithelium constitute the main 
effector sites, harboring large populations of activated T cells 
and antibody-secreting plasma cells.  13  As we discuss below, the 
LP may also contribute to the induction of tolerance, as a site 
of antigen uptake and loading of the migratory dendritic cells 
(DCs) that encounter na  ï  ve T cells in the mLNs (  Figure 1 ). 
 There is considerable evidence that the organized structures of 
the GALT (PP and isolated lymphoid follicles) are critical for the 
immune recognition of particulate antigens such as bacteria and 
viruses. This reflects the special ability of the so-called microfold 
cells (M cells) present in the epithelium of PP / isolated lymphoid 
follicles to actively transport material from the gut lumen into 
the lymphoid areas of the GALT  14   ( Figure 1  ). It is less clear if 
M-cell-mediated antigen uptake into GALT also plays a role 
in oral tolerance to soluble antigens. Targeting protein antigen 
directly to M cells has been reported to facilitate tolerance induc-
tion,  15  and one study observed that inhibition of PP development 
during gestation reduced oral tolerance to protein but not hap-
tens in adult mice.  16   However, other studies reported normal 
oral tolerance induction in the absence of PP,  17,18   and oral tol-
erance could be induced in spliced out intestinal loops, irre-
spective of the absence or presence of PP in the respective gut 
fragment.  19  On balance, it seems that antigen uptake by PP and 
isolated lymphoid follicles might play a subordinate role in oral 
tolerance to proteins, but may be more important in the analo-
gous process that controls immune responses to commensal 
bacteria (see below). 
  In contrast, there is mounting evidence that antigen uptake 
by DCs in the LP underlying regular villus epithelium is crucial 
for the induction of tolerance to soluble antigens in the small 
intestine (  Figure 1  ). Despite the low pH in the stomach and 
the presence of proteolytic enzymes that can degrade nutrients 
in the upper gastrointestinal tract, some food components are 
resistant to degradation and immunogenic material enters the 
            Figure 1                        Mechanisms of antigen uptake in gut-associated lymphoid 
tissue (GALT) and lamina propria. (  a  ) In organized tissues of the GALT 
such as Peyer  ’  s patches and isolated lymphoid follicles, specialized 
microfold cells (M cells) in the epithelium overlying the lymphoid follicles 
mediate transcellular transport of particulate material including intestinal 
microbiota (I). This antigen is then passed on to dendritic cells (DCs) that 
lie either below the epithelium or in a   “  pocket  ”   created at the basolateral 
surface of the M cell. Production of CCL20 by surrounding epithelial cells 
can attract further DCs via their expression of CCR6.  86   Some DCs in the 
GALT may also take up antigen directly from the lumen.  87   (  b  ) CD103        +         
DCs in the lamina propria underlying normal villus epithelium also play 
a critical role in presenting antigen for the induction of tolerance. They 
may acquire soluble antigens that have diffused through epithelial tight 
junctions (II), or that have been transferred across epithelial cells by 
transcellular routes (III). Exosomes containing antigen derived from 
class II MHC        +         enterocytes may be taken up by DCs (IV). CX3CR1  high   
macrophages have also been reported to capture luminal antigens by 
extending processes through the epithelial layer and they may pass this 
on to neighboring CD103        +         DCs (V). There may also be a few M cells 
within villus epithelium  88   (not depicted).   234  VOLUME 5 NUMBER 3 | MAY 2012 | www.nature.com/mi
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intestinal lumen. Orally administered antigen has been detected 
in the gut epithelium and LP within minutes after feeding,  20  and 
we observed antigen-loaded CD11c      +       cells in the LP 30 – 60   min 
after feeding mice labeled dextran or ovalbumin.  21  
  How luminal antigen gains access to these DCs through the 
supposedly impermeable epithelial barrier remains something 
of a mystery. Material of low molecular weight, such as haptens 
and polypeptides, may pass directly across the epithelium by 
paracellular diffusion through pores in the tight junctions con-
necting epithelial cells. Conversely, larger molecular complexes 
can be taken across enterocytes by transcytosis after fluid phase 
uptake at the apical membrane ( Figure 1 , see ref. 22   for a recent 
review on intestinal permeability). Antigenic material may also 
reach the LP within exosomes derived from major histocompat-
ibility complex class II  –  expressing enterocytes. Exosomes are 
formed when major histocompatibility complex class II loading 
compartments fuse with endosomes containing only partially 
degraded proteins. Notably, exosomes can be taken up efficiently 
by antigen-presenting cells and, when isolated from serum of 
antigen-fed mice, they are capable of inducing tolerance in 
recipient mice.  23   Recently, attention has focused on the idea 
that a population of LP myeloid cells expressing the chemokine 
receptor CX3CR1 may be able to sample the intestinal lumen 
by extending cellular processes across the epithelial barrier  24  
without perturbing tight junctions and epithelial integrity.  25  
Although it has been speculated that these CX3CR1  high   cells 
might facilitate antigen uptake  in vivo  ( Figure 1 ), the frequency 
of transepithelial protrusions varies markedly between mouse 
strains and between the various segments of the intestine.  26,27  
Finally, our own and other work has shown that the CX3CR1  high  
cells in LP do not appear to be   bona fide   DCs, as they do not 
migrate from LP to mLNs and cannot present luminal antigen 
to naive T cells.  28 – 30   Nevertheless, they do seem to be loaded 
efficiently with antigen and hence may play an accessory role, 
by passing it on to neighboring migratory DCs for transport and 
presentation. As discussed below, CX3CR1  high  cells may also be 
important for local differentiation of the Tregs needed to main-
tain oral tolerance. Furthermore, as the transepithelial dendrites 
from CX3CR1      +        myeloid cells in the LP have been shown to 
interact with bacteria in the lumen, they may play a specific role 
in inducing tolerance to commensal bacteria.  31  However, orally 
administered inert particles or nonpathogenic bacteria appear 
to localize preferentially in organized tissues of the GALT rather 
than the villous LP,  32,33   indicating that the efficient uptake of 
particulate material usually requires follicle-associated epithelia 
and M cells. In conclusion, the nature of the antigen determines 
its route of uptake. Particulate material and microbiota mostly 
enter into GALT by M-cell-mediated transcytosis, whereas solu-
ble antigens induce oral tolerance after being taken up by DCs 
in the LP and, to a lesser extent, the GALT.     
  BEYOND THE GUT: DISSEMINATION OF 
INTESTINAL ANTIGEN 
  As we have discussed, one of the characteristic features of oral 
tolerance to soluble antigens is that it can involve the entire 
animal. This is difficult to explain in the context of current 
views on anatomical compartmentalization within the mucosal 
immune system, as antigen uptake and recognition restricted 
to the LP, GALT, and mLNs should limit the resulting effects to 
the intestinal mucosa. One explanation for this could be that 
orally administered antigens can disseminate systemically via 
blood and lymph (  Figure 2  ). Food protein can be detected in 
the blood of mice and humans soon after eating.  34,35   This  does 
not go unnoticed by the immune system, as feeding antigen 
can induce simultaneous expression of the activation marker 
CD69 and behavioral changes in T cells in mLNs and periph-
eral LNs.  36,37   Furthermore, serum from protein-fed mice can 
induce antigen-specific tolerance in naive recipients, indicating 
the presence of tolerogenic material.  38  This raises the important 
question of how and where this absorbed antigen can contribute 
to oral tolerance induction. 
  One possible site is the liver. The portal vein drains blood 
from the intestine to the liver ( Figure 2 ) and injection of antigen 
directly into the portal vein is well known to induce antigen-
specific tolerance.  39   Conversely, diverting the blood flow away 
from the liver by portocaval shunting prevents the induction of 
oral tolerance.  40,41  The liver contains several subsets of special-
ized antigen-presenting cells that may contribute to tolerance 
induction. Liver sinusoidal endothelial cells efficiently sample 
circulating antigen, can act as antigen-presenting cells, and have 
been shown to induce tolerance rather than active immunity. 
Antigen presentation by Kupffer cells and conventional liver 
DCs also favors tolerance over immunity (reviewed in ref. 39    ), 
whereas plasmacytoid DCs are particularly abundant in the liver 
and have been implicated in the induction of systemic tolerance 
to orally administered proteins and haptens.  20   Antigen  reach-
ing beyond the liver into peripheral LNs and spleen might be 
expected to induce tolerance in these sites, as it will be presented 
by resident DCs in the absence of costimulation, leading to the 
induction of anergy or Tregs. 
      Figure 2                        Routes by which intestinally derived antigen might 
disseminate and generate widespread systemic tolerance. Antigen 
taken up into Peyer  ’  s patches (PP) or lamina propria may enter the 
bloodstream via the portal vein, first reaching the liver before it becomes 
distributed into the wider circulation. Systemic tolerance may then occur 
because of antigen presentation in the liver by sinusoidal endothelial 
cells, tolerogenic conventional dendritic cells (DCs) or plasmacytoid DCs 
(pDCs), or because antigen reaching peripheral lymph nodes (pLNs) 
will be presented by resident DCs in the absence of costimulation. Free 
antigen taken up into afferent intestinal lymph will pass through the 
mesenteric lymph nodes (mLNs) and eventually enter the bloodstream 
via the thoracic duct.   MucosalImmunology | VOLUME 5 NUMBER 3 | MAY 2012  235
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 In contrast to this evidence that dissemination of fed antigen is 
important for oral tolerance, we found that the transport of anti-
gen from the LP into the mLNs by CD103      +       DCs is the key event 
for inducing the systemic consequences of oral tolerance.  42  The 
constitutive migration of DCs into draining LNs requires the 
chemokine receptor CCR7.  43  Consequently, genetic deficiency 
in CCR7 prevents the recognition of fed antigen by T cells in 
the mLNs and impairs the induction of oral tolerance.  44   Other 
reports have also emphasized a central role for the mLNs in oral 
tolerance induction. Oral tolerance is abrogated in lymphotoxin 
    -deficient mice lacking all LNs and PP, but can be restored 
by selective rescue of mLN development.  18   Moreover,  surgical 
removal of mLNs prevented the induction of oral tolerance in 
wild-type mice.  44   The reason for these discrepant findings on 
the relative roles of the mLNs vs. more widespread dissemina-
tion of antigen to the liver and elsewhere is unknown. However, 
the concentration of antigen reaching the circulation may vary 
considerably depending on the nature and dose of antigen, as 
well as the health status of the animals. Therefore, subtle differ-
ences in housing conditions and experimental models might 
explain some of the differences. Nevertheless, we consider that 
the mLN is the crucial site involved in oral tolerance induc-
tion,  42   and recently there has been considerable progress in 
understanding the molecular mechanisms involved.     
  MIGRATORY CD103        +         DCS AND LOCAL CONDITIONING 
CREATE A TOLEROGENIC ENVIRONMENT IN THE MLNs 
 The integrin chain    E  (CD103) is expressed by a major popula-
tion of migratory DCs present in the LP. These CD103      +       DCs that 
carry antigen from the intestine do not travel beyond the mLNs 
and are largely excluded from entering the bloodstream and 
other lymphatic organs.  45  CD103     +       DCs from the LP and mLNs 
have a unique ability to induce the expression of gut-  homing 
molecules on T cells,  46   and are particularly potent in inducing 
the generation of Foxp3      +        Tregs. 47   Both of these properties are 
linked to the ability of CD103      +       DCs to metabolize dietary retin-
oids (Vitamin A) to retinoic acid (RA). RA is sufficient to induce 
the gut-homing molecules CCR9 and    4    7  integrin on activated 
T cells   in vitro  , and the ability of CD103      +        DCs to induce these 
homing molecules is blocked by antagonists of RA synthesis 
and / or signaling. 48  Moreover, CD103     +       DC-derived RA can act 
as a cofactor in the transforming growth factor-   (TGF-  )-medi-
ated conversion of naive CD4 T cells into Tregs.  47  CD103     +       DCs 
can themselves activate TGF-     by virtue of their expression of 
the     v    8   integrin, and selective lack of     v    8   on these DCs abro-
gates the induction of Tregs and oral tolerance.  49,50  
  The special properties of mucosal CD103      +        DCs are not 
shared by CD103      +        DCs from other tissues and seem to be 
imprinted by the gut tissue itself.  51   In particular, gut epi-
thelial cells promote a tolerogenic phenotype in DCs via 
the production of thymic stromal lymphopoietin, TGF-   , 
and RA.  52,53   RA seems to play a crucial role in defining the 
properties of CD103      +        DCs, not only mediating their effects 
on T cells, but also helping to induce and maintain their 
unique phenotype.  54   DCs isolated from the gut of mice fed 
an retinoid-free diet have reduced levels of RA-producing 
enzymes and RA can induce its own generation by DCs 
  in vitro . 55,56  The sources of RA in the intestine may include RA 
produced by epithelial cells that metabolize retinoids taken up 
from the diet or from the bile.  57   Other external factors present 
in the gut may also contribute to the production of RA by local 
DCs, such as ligands for Toll-like receptor 2,  58   granulocyte-
 macrophage colony-stimulating factor, and interleukin-4 (IL-4).  59  
Whether CD103 itself plays any role in the function of these DCs 
is unclear, although the fact that wild-type Tregs cannot prevent 
colitis in CD103-deficient recipients could support this idea.  60  
 Although these findings suggest that intestinal CD103      +       DCs 
are imprinted with their unique functions in the mucosa itself, 
the situation appears to be more complex  in vivo . Our own group 
and that of Molenaar   et al.  61   have found that the full ability of 
intestine-derived DCs to drive gut tropism in T cells requires 
cooperation with nonhematopoietic stromal cells in the mLNs.  62  
Stromal cells from mLNs express higher levels of RA-producing 
enzymes than peripheral LN stromal cells. Moreover, peripheral 
LNs fail to support the induction of gut-homing molecules on 
T cells, even when transplanted into the intestinal mesentery, 
where they are populated by gut-derived DCs.  62  Similarly, stro-
mal cells from mLNs but not from skin-draining LNs support 
the generation of Foxp3      +        Tregs (S Cording, B Wahl, J H  ü  hn, 
O Pabst, unpublished observations). Indeed, LN stromal cells 
of the mLNs and skin-draining LNs possess unique transcrip-
tome profiles.  63  Thus, tissue-specific differences in stroma help 
generate a uniquely tolerogenic environment in mucosal LNs, 
and additional imprinting of CD103      +       DCs in this environment 
is needed for them to play their full role in regulating intestinal 
immune  responses.   
  MECHANISMS OF ORAL TOLERANCE 
  As with other models of peripheral tolerance, a number of 
different mechanisms have been implicated in oral tolerance, 
including active regulation by Tregs, as well as clonal deletion 
and clonal anergy of T cells. In this context, Weiner   et al.  4,64,65  
suggested that the mechanism of oral tolerance was deter-
mined by the feeding regime used, with single high doses of 
antigen favoring clonal deletion or anergy, whereas multiple 
low doses of antigen were linked to T-cell-mediated suppres-
sion. However, more recent work has found that the frequencies 
of Foxp3      +        Tregs in oral tolerance were highest when a high 
dose of antigen was used.  66   Moreover, there is little direct evi-
dence that clonal deletion and / or anergy contribute to oral toler-
ance in the presence of a polyclonal T-cell repertoire, although 
the direct entry of free antigen to the mLNs could account for 
such effects. Nevertheless, the influence of antigen dose on the 
mode of suppression needs to be re-evaluated. 
  The fact that CD103      +        DCs and the mLNs seem to have 
special abilities to drive the generation of Tregs, and both are 
required for the induction of oral tolerance, suggests that Tregs 
should play a central role in oral tolerance. Indeed, the induc-
tion of T cells with active suppressor function was first shown 
in oral tolerance several decades ago.  12   Although most of this 
work pre-dated the discovery of Foxp3 and molecularly defined 
subsets of Tregs, it has been substantiated subsequently using 236  VOLUME 5 NUMBER 3 | MAY 2012 | www.nature.com/mi
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more modern techniques. Transfer of CD4      +      CD25     +       CD4 T cells 
(which are highly enriched in Foxp3      +        Tregs) can transfer oral 
tolerance to na ï ve animals, and depletion of CD25      +       cells  in vivo  
abrogates oral tolerance.  67   A number of different Tregs have 
been implicated in oral tolerance, including IL-10-producing 
Tr1 T cells and Th3 T cells,  12   in addition to the Foxp3      +        Tregs 
that are currently the focus of most attention. As much of the lit-
erature on  “ Tr1 ”  cells and  “ Th3 ”  T cells in the intestine was pub-
lished before the Foxp3 era, it is not always possible to define the 
exact nature of the Tregs that have been described. However, it is 
known that Foxp3      +       and Foxp3   –   populations of IL-10-secreting 
Tregs are present in the mucosa  68   and, judged by their secre-
tion of TGF-  , the TH3 cells described by the Weiner group are 
likely to be similar to, if not identical to, what we now know as 
Foxp3      +        Tregs. 
  The best characterized population of Tregs found in other 
forms of tolerance expresses Foxp3. Foxp3      +       Tregs come in two 
distinct flavors, natural Foxp3      +        Tregs (nTregs) and induced 
Foxp3      +       (Tregs (iTregs).  69  nTregs are selected in the thymus as a 
consequence of their reactivity to self, whereas iTregs are gener-
ated from na  ï  ve CD4 T cells in the peripheral immune system. 
Whereas nTregs are stable  in vivo , 70  iTregs can differentiate into 
other helper T cells under inflammatory conditions.  71  Still, under 
noninflammatory conditions, Foxp3      +        Treg-mediated immune 
regulation is a robust phenomenon and may confer longlasting 
oral tolerance. Interestingly, oral tolerance to ovalbumin could 
not be induced in a mouse model in which nTregs but not iTregs 
could be generated, suggesting that this model required periph-
eral conversion of naive CD4 T cells into iTregs.  72  This observa-
tion is consistent with the findings described above showing that 
the mLN provides a specialized microenvironment in which 
CD103      +       DCs drive the selective differentiation of iTregs, as well 
as our own observation that depletion of ovalbumin-induced 
Tregs abolished oral tolerance.  73    
  A FRAMEWORK FOR THE GENERATION AND 
MAINTENANCE OF ORAL TOLERANCE 
 Given the considerable amount of foreign protein antigen taken 
up with our daily diet and the knowledge that oral tolerance can 
be maintained for several months after a single encounter with 
antigen  12,74  one would envision that the generation of iTregs in 
response to intestinal antigens might be a continuously ongoing 
process. Pathways by which this can occur  in vivo  are suggested 
by our recent work showing that the induction and maintenance 
of oral tolerance may reflect a multi-step process involving both 
lymphoid organs and the mucosal tissues (  Figure 3 ). 73   Key  to 
this is our observation that oral tolerance was reduced in mice 
lacking     7   integrin or its ligand MadCAM-1 (mucosal vascu-
lar addressin cell adhesion molecule 1), whose interaction is 
critical to enable gut homing of T cells.  75   Importantly, neither 
gene deficiency impaired the initial generation of iTregs in the 
mLNs, and defective oral tolerance in    7 -integrin-deficient but 
not MadCAM-1-deficient mice could be rescued by adoptive 
transfer of     7  -competent T cells. Thus, oral tolerance requires 
the     7  -integrin-dependent gut homing of iTregs after their ini-
tial generation in the mLNs.  73  In support of this idea, the group 
of Rodrigo Mora recently observed defective oral tolerance in 
CCR9-deficient mice.  76   CCR9 along with     7   integrin  targets 
T cells to the small intestine  77   and, as we found in     7 -integrin-
deficieint mice, defective oral tolerance in CCR9-deficieint mice 
could be restored by transfer of wild-type T cells.  76  However, in 
our hands, CCR9-deficient mice developed normal oral toler-
ance to ovalbumin (independent unpublished observations in 
the Mowat and Pabst labs), suggesting there may be differences 
in individual strains of CCR9-deficient mice, or that differences 
in the composition of the microbiota may influence the impact 
of CCR9 on oral tolerance. There are controversial reports 
on the capacity to induce oral tolerance in germ-free mice 
devoid of live intestinal bacteria.  78,79   Yet, no doubt, the intesti-
nal microbiota has profound effects on the gut immune system; 
for example, distinct bacterial species may favor or disfavor 
Foxp3      +       Treg induction.  80  Thus, it is conceivable that differences 
in microbiota composition may also affect oral tolerance. 
 The second crucial finding to arise from our own studies was 
that the mLN-derived iTregs in antigen-fed mice appeared to 
undergo secondary expansion after arrival in the small intestinal 
LP (  Figure 3  ). Both the expansion of iTregs and the induction 
of oral tolerance required the chemokine receptor CX3CR1, as 
they were abrogated in CX3CR1-deficient mice. This correlated 
with reduced production of IL-10 by myeloid cells in the LP 
      Figure 3                        A multistep model of oral tolerance to soluble antigens. Oral 
tolerance is initiated by the migration of antigen-loaded CD103        +         dendritic 
cells (DCs) from the lamina propria (LP) into the draining mesenteric 
lymph nodes (mLNs; I). In the mLN, retinoic acid (RA) produced by DCs 
and local stromal cells induces the expression of gut-homing receptors 
      4        7   integrin and CCR9 on antigen-specific T cells and favors the 
transforming growth factor-     (TGF-    )-dependent differentiation of Foxp3        +         
induced regulatory T cells (iTregs; II). These committed Tregs home 
back to the intestinal lamina propria (III), where they undergo secondary 
expansion under the influence of interleukin-10 (IL-10) produced by 
CX3CR1  high   macrophages in the lamina propria (IV). In a putative 
fifth step (V), some of the Tregs may exit from the mucosa via lymph 
and  /  or bloodstream, disseminating throughout the immune system, and 
promoting the systemic consequences of oral tolerance. Foxp3, forkhead 
box P3; MadCAM-1, mucosal vascular addressin cell adhesion molecule 1.   MucosalImmunology | VOLUME 5 NUMBER 3 | MAY 2012  237
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and could be restored with IL-10-producing wild-type macro-
phages.  73  This suggestion that IL-10 produced in the mucosa is 
needed to drive or maintain local Foxp3 iTregs is supported by 
work from Murai   et al. , 81   which showed that IL-10 production 
by CD11b      +        myeloid cells in LP is needed to maintain Foxp3 
expression by iTregs in the colon. Thus, secondary maintenance 
of iTregs by IL-10-producing gut-resident macrophages may be 
common to both classical oral tolerance to proteins in the small 
intestine and in tolerance to commensal bacteria in the colon. 
 On the basis of these findings, we propose that both forms of 
mucosally induced tolerance are initiated in the draining LNs, 
but are then expanded and sustained in the LP. In the case of oral 
tolerance induced in the small intestine, cooperative production 
of RA by antigen-loaded, gut-derived CD103      +        DCs and mLN 
stromal cells leads to the imprinting of gut-homing molecules 
on specific T cells. Some of these also begin to differentiate into 
Foxp3      +        iTregs. These   “  primed  ”   iTregs then leave the mLN and 
home to the small intestine, where they undergo secondary 
expansion and are sustained by IL-10-producing CX3CR1  high  
myeloid cells. Clearly, this can explain the ability of oral toler-
ance to maintain an inhibitory environment that can prevent 
hypersensitivity in the mucosa itself. Interestingly, intestinal 
antigen may also sustain Tregs in the gut. The T-cell receptor 
repertoire of Tregs present in the small intestinal LP showed a 
higher overlap with the Treg repertoire of gut-draining mLNs 
than skin-draining LNs,  82  and many Tregs present in the colon 
seem to arise only after response to microbiota-derived anti-
gen.  83   Thus, there is a concept emerging that intestinal antigen 
not only triggers the generation of iTregs but might subsequently 
allow for the maintenance of an antigen-specific Treg pool in the 
intestine. As Tregs can produce TGF-     and may even convert 
into follicular helper T cells within GALT,  84  these processes may 
also account for the production of noninflammatory immu-
noglobulin A responses against intestinal antigens, something 
that plays a particularly crucial role in maintaining the local 
symbiotic relationship between the host and its microbiota. Less 
obvious is how these local processes could suppress immune 
responses systemically. As a potential explanation, we speculate 
that a fraction of Tregs that have undergone secondary expan-
sion in the LP may exit the tissue and enter the circulation either 
via the draining lymphatics, or directly via the bloodstream. In 
this respect, it is interesting to note that Foxp3      +       Tregs constitute 
a significant population in skin-draining afferent lymphatics.  85  
Escape from the LP in this way could allow iTregs generated 
initially in the intestinal lymphoid tissues to act more generally, 
either by directly inhibiting systemic effector T cells or by fueling 
generation of further iTregs in systemic tissues by the process of 
infectious tolerance. Further experiments should explore these 
processes in more detail. It will also be important to understand 
why this dissemination of iTreg-dependent tolerance only seems 
to occur with soluble antigens, whereas tolerance to microbiota 
is limited to the intestinal tissues.     
  CONCLUSIONS 
 Oral tolerance is a multifaceted process and multiple cellular and 
molecular processes may be needed to ensure durable tolerance 
to harmless intestinally derived antigens, both in the mucosa 
itself and in the systemic immune system. The chain of events 
we propose here suggests that tolerance involves stepwise and 
anatomically defined processes of induction, maintenance, and 
migration of Tregs that ensure immune regulation in all appro-
priate tissues. The model also highlights how these processes are 
dependent on the unique properties of the intestinal immune 
system and these may allow the identification of new targets for 
modulating  tolerance.     
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